Skip to main content
. 2006 Aug 11;66(2):151–157. doi: 10.1136/ard.2006.054056

graphic file with name ar54056.f3.jpg

Figure 3 All three groups of patients showed increased intensity of the anti‐CC chemokine receptor 2 (CCR2)–phycoerythrin (PE) signal on CD4+ CXCR3+ T lymphocytes compared with CD4+ CXCR3− cells at weeks 0 and 12 (p<0.001). This CCR2 density was further increased compared with controls in all three groups of patients (p<0.001). Median values are marked by horizontal lines.